CD70 and hereditary clear cell renal cell carcinoma: Our published study on renal cell carcinomas used the murine and humanised form of our therapeutic anti-CD70 (1F6 mAb) as primary antibody for detection of CD70 expression in frozen tissues and, up to this point, represented the most extensive analysis of CD70 protein expression in renal cell carcinoma.